Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Share-based Compensation (2023 - 2025)

Bioregenx's Share-based Compensation history spans 2 years, with the latest figure at -$254021.0 for Q4 2025.

  • Quarterly results put Share-based Compensation at -$254021.0 for Q4 2025, down 118.69% from a year ago — trailing twelve months through Sep 2025 was $1.6 million (up 8.14% YoY), and the annual figure for FY2024 was $2.9 million, up 27.37%.
  • Share-based Compensation for Q4 2025 was -$254021.0 at Bioregenx, down from $254021.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.7 million in Q1 2024 to a low of -$331303.0 in Q3 2024.